Nobe Koji, Yamazaki Taigi, Tsumita Naoki, Hashimoto Terumasa, Honda Kazuo
Department of Pharmacology, School of Pharmaceutical Sciences, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan.
J Pharmacol Exp Ther. 2009 Mar;328(3):940-50. doi: 10.1124/jpet.108.144907. Epub 2008 Dec 2.
Urinary bladder dysfunction, which is one of the most common diabetic complications, is associated with alteration of bladder smooth muscle contraction. However, details regarding the responses under high-glucose (HG) conditions in diabetes are poorly understood. The objective of this study was to identify a relationship between extracellular glucose level and bladder smooth muscle contraction in diabetes. Bladder smooth muscle tissues were isolated from spontaneously type II diabetic (ob/ob mouse; 16-20 weeks of age, male) and age-matched control (C57BL mouse) mice. Carbachol (CCh) induced time- and dose-dependent contractions in ob/ob and C57BL mice; however, maximal responses differed significantly (14.34 +/- 0.32 and 12.69 +/- 0.22 mN/mm(2) after 30 microM CCh treatment, respectively; n = 5-8). Pretreatment of bladders under HG conditions (22.2 mM glucose; concentration is twice that of normal glucose for 30 min) led to enhancement of CCh-induced contraction solely in diabetic mice (15.9 +/- 0.26 mN/mm(2); n = 5). Basal extracellular glucose-dependent enhancement of bladder contraction in diabetes was documented initially in this study. The correlation between intracellular calcium concentration and contraction was enhanced only in the ob/ob mouse. This enhancement of contraction and total protein kinase C (PKC) activity were inhibited by pretreatment with not only a PKC inhibitor (rottlerin) but also with a rho kinase inhibitor, fasudil [1-(5-isoquinolinesulfonyl)homopiperazine HCl]. These reagents also suppressed the differences between ob/ob and C57BL mouse bladder contractions under HG conditions. The data indicated that glucose-dependent enhancement of contraction in diabetic bladder is involved in the activation of the rho kinase and calcium-independent PKC pathways. This dysfunction may contribute to bladder complications such as detrusor overactivity and reduced bladder capacity in diabetes.
膀胱功能障碍是最常见的糖尿病并发症之一,与膀胱平滑肌收缩改变有关。然而,糖尿病患者在高糖(HG)条件下的反应细节尚不清楚。本研究的目的是确定糖尿病患者细胞外葡萄糖水平与膀胱平滑肌收缩之间的关系。从自发性II型糖尿病(ob/ob小鼠;16 - 20周龄,雄性)和年龄匹配的对照(C57BL小鼠)小鼠中分离膀胱平滑肌组织。卡巴胆碱(CCh)在ob/ob和C57BL小鼠中诱导时间和剂量依赖性收缩;然而,最大反应有显著差异(分别在30μM CCh处理后为14.34±0.32和12.69±0.22 mN/mm²;n = 5 - 8)。在HG条件下(22.2 mM葡萄糖;浓度是正常葡萄糖的两倍,处理30分钟)对膀胱进行预处理,仅在糖尿病小鼠中导致CCh诱导的收缩增强(15.9±0.26 mN/mm²;n = 5)。本研究首次记录了糖尿病患者膀胱收缩的基础细胞外葡萄糖依赖性增强。细胞内钙浓度与收缩之间的相关性仅在ob/ob小鼠中增强。这种收缩增强和总蛋白激酶C(PKC)活性不仅被PKC抑制剂(罗特列林)预处理抑制,也被rho激酶抑制剂法舒地尔[1 -(5 - 异喹啉磺酰基)高哌嗪盐酸盐]抑制。这些试剂也抑制了HG条件下ob/ob和C57BL小鼠膀胱收缩之间的差异。数据表明,糖尿病膀胱中葡萄糖依赖性收缩增强与rho激酶和钙非依赖性PKC途径的激活有关。这种功能障碍可能导致膀胱并发症,如糖尿病患者的逼尿肌过度活动和膀胱容量减少。